Company Name, Ticker, Suppliers, else..

Maia Biotechnology Inc (NYSEAMER: MAIA)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Maia Biotechnology Inc 's

Name: Maia Biotechnology Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MAIA Sales vs. its Competitors Q2 2026

Comparing the current results to its competitors, Maia Biotechnology Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 98.78 %, recorded in the same quarter.

• List of MAIA Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Maia Biotechnology Inc recorded a net loss, as well as most of its competitors.

<< MAIA Stock Performance Comparisons

Maia Biotechnology Inc 's Comment on Competition and Industry Peers

The biotechnology industry is characterized by rapid technological advancements and strong intellectual property protections. The company faces competition from major pharmaceutical and biotechnology firms, academic institutions, governmental agencies, and both public and private research organizations. In the non-small cell lung cancer indication, competitors include Merck, Regeneron, Eli Lilly, and Roche. Competitive factors include efficacy, safety, convenience, diagnostic effectiveness, pricing, and reimbursement. Additionally, competitors may be developing therapies with similar mechanisms or targeting the same clinical indications.

<< See the full list of MAIA competitors

*Market share is calculated based on total revenue.

MAIA's Stock Performance relative to its Competitors

Publicly Traded Peers of Maia Biotechnology Inc

Verastem Inc
Share Performance

-18.55%

One Year

Verastem Inc

Profile

Verastem Inc is a biopharmaceutical company that focuses on discovering and developing medicines to treat cancer by targeting the underlying biology of the disease. They employ a research-driven business model to identify novel therapeutic candidates, evaluate their potential through preclinical and clinical trials, and bring them to market with the goal of improving patient outcomes. Verastem emphasizes innovation, precision medicine, and strategic collaborations to advance their pipeline of cancer therapeutics.

More about Verastem Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 808.937 mill.	$ 87.526 mill.	$ -202.698 mill.

Fate Therapeutics Inc
Share Performance

+13.12%

This Quarter

Fate Therapeutics Inc

Profile

Fate Therapeutics Inc's business model revolves around the development and commercialization of innovative cell-based therapies to treat various diseases.

More about Fate Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 300.993 mill.	$ 6.491 mill.	$ -125.996 mill.

Bio Green Med Solution Inc
Share Performance

-8.11%

30 Days

Bio Green Med Solution Inc

Profile

Bio Green Med Solution supplies and trades fire safety equipment and protective products.

More about Bio Green Med Solution Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 4.888 mill.	$ 1.861 mill.	$ -13.234 mill.

Atossa Therapeutics Inc
Share Performance

-48.14%

This Quarter

Atossa Therapeutics Inc

Profile

Atossa Therapeutics Inc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for breast conditions and oncology.

More about Atossa Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 22.405 mill.	$ - mill.	$ -37.709 mill.

Aptevo Therapeutics Inc
Share Performance

-22.95%

Over The Past 5 Days

Aptevo Therapeutics Inc

Profile

Aptevo Therapeutics Inc operates as a biotechnology company that focuses on the development of novel oncology and hematology therapeutics. The company primarily generates revenue through the sale of its products and potential collaborations with other pharmaceutical companies.

More about Aptevo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 2.249 mill.	$ - mill.	$ -26.505 mill.

19 more competitors available

Sources: Maia Biotechnology Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 4:33 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Maia Biotechnology Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.